Søren Morgenthaler Echwald
Vorstandsvorsitzender bei Anapa Biotech A/S
Aktive Positionen von Søren Morgenthaler Echwald
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Anapa Biotech A/S
 Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Vorstandsvorsitzender | - | - |
Ranger Biotechnologies A/S
 Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Søren Morgenthaler Echwald
Ehemalige bekannte Positionen von Søren Morgenthaler Echwald
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EXIQON A/S | Corporate Officer/Principal | - | - |
Statistik
International
| Dänemark | 4 |
Operativ
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Commercial Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Anapa Biotech A/S
Anapa Biotech A/S Miscellaneous Commercial ServicesCommercial Services Anapa Biotech A/S provides molecular tools to enhance the performance of natural nucleic acids. Its technology is the proprietary Twisted Intercalating Nucleic Acid molecules. The company was founded by Gorm Lisby and Henrik Westh in 2002 and is headquartered in Hørsholm, Denmark. | Commercial Services |
Ranger Biotechnologies A/S
Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |
